Histological analyses verified that LOXL2 suppression decreased lung metastatic burden and increased CD8 cell infiltration into both the primary and metastatic tumors (Fig. 3g and h, Supplementary Fig. 6b–e). Here, CD8A is linked to metastatic neoplasm.